Literature DB >> 20703629

Prediction of the period of psychotic episode in individual schizophrenics by simulation-data construction approach.

Chun-Jung Huang1, Hsiao-Fan Wang, Hsien-Jane Chiu, Tsuo-Hung Lan, Tsung-Ming Hu, El-Wui Loh.   

Abstract

Although schizophrenia can be treated, most patients still experience inevitable psychotic episodes from time to time. Precautious actions can be taken if the next onset can be predicted. However, sufficient information is always lacking in the clinical scenario. A possible solution is to use the virtual data generated from limited of original data. Data construction method (DCM) has been shown to generate the virtual felt earthquake data effectively and used in the prediction of further events. Here we investigated the performance of DCM in deriving the membership functions and discrete-event simulations (DES) in predicting the period embracing the initiation and termination time-points of the next psychotic episode of 35 individual schizophrenic patients. The results showed that 21 subjects had a success of simulations (RSS) ≥70%. Further analysis demonstrated that the co-morbidity of coronary heart diseases (CHD), risks of CHD, and the frequency of previous psychotic episodes increased the RSS.

Entities:  

Mesh:

Year:  2009        PMID: 20703629     DOI: 10.1007/s10916-009-9294-5

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  16 in total

1.  Causes of the excess mortality of schizophrenia.

Authors:  S Brown; H Inskip; B Barraclough
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

Review 2.  The role of early warning symptoms in the detection and prevention of relapse in schizophrenia.

Authors:  P B Fitzgerald
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

3.  Hierarchy of classes of personal illness.

Authors:  G A Foulds; A Bedford
Journal:  Psychol Med       Date:  1975-05       Impact factor: 7.723

4.  Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

Authors:  D Wiersma; F J Nienhuis; C J Slooff; R Giel
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

5.  One-year outcome of schizophrenic patients--the interaction of chronicity and neuroleptic treatment.

Authors:  W Gaebel; A Pietzcker
Journal:  Pharmacopsychiatry       Date:  1985-05       Impact factor: 5.788

Review 6.  Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.

Authors:  A H Barnett; P Mackin; I Chaudhry; A Farooqi; R Gadsby; A Heald; J Hill; H Millar; R Peveler; A Rees; V Singh; D Taylor; J Vora; P B Jones
Journal:  J Psychopharmacol       Date:  2007-06       Impact factor: 4.153

Review 7.  The concept of basic symptoms in schizophrenic and schizoaffective psychoses.

Authors:  G Huber; G Gross
Journal:  Recenti Prog Med       Date:  1989-12

8.  Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics.

Authors:  T H Lan; E W Loh; M S Wu; T M Hu; P Chou; T Y Lan; H-J Chiu
Journal:  Mol Psychiatry       Date:  2008-01-08       Impact factor: 15.992

9.  Stages of onset of schizophrenic psychosis.

Authors:  J P Docherty; D P Van Kammen; S G Siris; S R Marder
Journal:  Am J Psychiatry       Date:  1978-04       Impact factor: 18.112

10.  Neural network analysis in pharmacogenetics of mood disorders.

Authors:  Alessandro Serretti; Enrico Smeraldi
Journal:  BMC Med Genet       Date:  2004-12-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.